Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors

There is an unmet need for new therapies in metastatic ovarian cancer and basal-like breast cancer since no curative therapies are currently available. Immunotherapy has shown to be active in several solid tumors, but particularly more in those where a pre-activated immune state does exist. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcaraz-Sanabria, Ana, Baliu-Piqué, Mariona, Saiz-Ladera, Cristina, Rojas, Katerin, Manzano, Aránzazu, Marquina, Gloria, Casado, Antonio, Cimas, Francisco J., Pérez-Segura, Pedro, Pandiella, Atanasio, Gyorffy, Balázs, Ocana, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965148/
https://www.ncbi.nlm.nih.gov/pubmed/31998644
http://dx.doi.org/10.3389/fonc.2019.01486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965148/
https://www.ncbi.nlm.nih.gov/pubmed/31998644
http://dx.doi.org/10.3389/fonc.2019.01486

Ejemplares similares